SELP and ischemic stroke: The associations of sphingosine-1-phosphate with biomarkers of platelet activation, i.e., thromboxane B<sub>2</sub> and soluble P-selectin, as well as with clinical outcome in ischemic stroke or transient ischemic attack patients' subgroups with and without ASA has not yet been investigated.